Early research (Phase 1)Ended earlyNCT03478956
What this trial is testing
A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease
Who this might be right for
Ulcerative ColitisCrohn's Disease
Hoffmann-La Roche 24